Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 9/20 | 0.84 |
| ▸ | DRD4 | P21917 | 9/20 | 0.84 |
| ▸ | DRD3 | P35462 | 7/20 | 0.81 |
| ▸ | F2 | P00734 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23067879 | 1.00 | DRD2 (0.84) | DRD2DRD4DRD3F2POLB | |
| Hydrochloric Acid SCHEMBL8059381 | 0.90 | DRD2 (0.97) | DRD2DRD4DRD3MAPK1KDM4E | |
| Hydrochloric Acid SCHEMBL8055378 | 0.89 | DRD2 (0.97) | DRD2DRD4DRD3POLB | |
| SCHEMBL15829982 | 0.87 | DRD2 (0.66) | DRD2DRD4DRD3F2POLB | |
| SCHEMBL27465 | 0.86 | DRD2 (0.62) | DRD2DRD4DRD3F2POLB | |
| SCHEMBL29381067 | 0.86 | DRD2 (0.62) | DRD2DRD4DRD3F2POLB | |
| SCHEMBL14308606 | 0.85 | DRD2 (0.69) | DRD2DRD4DRD3F2POLB | |
| SCHEMBL11455127 | 0.85 | DRD2 (0.64) | DRD2DRD4DRD3F2POLB | |
| SCHEMBL16063133 | 0.85 | DRD2 (0.64) | DRD2DRD4DRD3F2POLB | |
| SCHEMBL13924808 | 0.84 | DRD2 (0.71) | DRD2DRD4DRD3F2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12364978-B2 | Anionic exchange-hydrophobic mixed mode chromatography resins | BIO-RAD LABORATORIES, INC. (US) | 2025-07-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12364978-B2 | Anionic exchange-hydrophobic mixed mode chromatography resins | ABCG2, SLC7A1, MSR1 | DRD2 2750/4885DRD4 1739/4885DRD3 2422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.